Clinical Trials Directory

Trials / Completed

CompletedNCT07058246

Effectiveness of Mime Therapy vs Conventional Therapy for Bell's Palsy

Effectiveness of Mime Therapy and Conventional Therapy for the Patients of Bell's Palsy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Elite College of Management Sciences, Gujranwala, Pakistan · Academic / Other
Sex
All
Age
25 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the effectiveness of mime therapy and conventional therapy for improving facial functional mobility and coordination.

Detailed description

This will be a Randomized Controlled Trial (RCT). Sample will be taken using Non-Probability Convenient Sampling. Sample size of 34 participants that will be randomly allocated into two groups using a coin toss method. Group A (intervention group) will receive mime therapy along with conventional therapy, while Group B (control group) will receive only conventional therapy were given 45 minutes per day for 3-4 sessions in a week for 3 weeks. Outcomes will be measured by using the Sunnybrook Facial Grading System for checking facial symmetry and the House-Brackmann Facial Grading System for measuring severity of paresis.

Conditions

Interventions

TypeNameDescription
OTHERMime therapy with Conventional therapyExperimental group was given mime therapy along with conventional therapy. Mirror therapy, Raising eyebrows as if surprised, Widening eyes in shock, blinking rapidly, Extreme smiling, Eye closure with dramatic expressions, exaggeration nose wrinkling. pouting and mouth opening, expression transitions. Total sessions given are 4-5 per week in 3 weeks consist of 45 mins. Number of repetitions are 5-10 with the hold of 5 second x 2 sets.
OTHERConventional therapyRaising and lowering eyebrows, Wrinkling nose, smiling, frowning, massage. Total sessions given are 4-5 per week in 3 weeks consist of 45 mins. Number of repetitions are 5-10 with the hold of 5 second x 2 sets.

Timeline

Start date
2025-04-01
Primary completion
2025-06-01
Completion
2025-07-01
First posted
2025-07-10
Last updated
2025-07-10

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07058246. Inclusion in this directory is not an endorsement.